He Jing, Pei Cheng, Ge Xin, Ma Jian-Min, Hu Ya-Guang
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.
Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Int J Ophthalmol. 2023 Mar 18;16(3):382-387. doi: 10.18240/ijo.2023.03.08. eCollection 2023.
To analyze and summarize the clinical and pathological features of ciliary body medulloepithelioma.
The clinical and pathological data of 11 patients (11 eyes) who were diagnosed with ciliary body medulloepithelioma at Beijing Tongren Hospital, Capital Medical University, from 2007 to 2021 were retrospectively analyzed.
The initial symptoms of 11 patients included vision loss (6 eyes), atrophia bulbi (1 eye), proptosis (2 eyes), and leukocoria (2 eyes). Most patients suffered with corneal opacity, anterior chamber flare and hyphema. Iris neovascularization and synechia, complicated cataract, and secondary glaucoma occurred in several cases. Three patients even had lens subluxation and retinal detachment. B-scan ultrasonography showed vitreous opacity and a medium-high uneven echo mass in the eyeball. Ultrasound biomicroscopy examination showed a spherical or hemispherical ciliary body mass with uneven internal echoes and irregular cystic spaces. All of the 11 patients were diagnosed with malignant ciliary body medulloepithelioma by pathological evidence. In this study, 6 patients had enucleation (2 patients had systemic chemotherapy after surgery), and the other 5 patients had local tumor resection (1 patient had plaque radiotherapy after surgery).
Ciliary body medulloepithelioma is a rare intraocular tumor and may be easily confused with retinoblastoma. Analyzing the clinical and pathological features of ciliary body medulloepithelioma is useful to further understand ciliary body medulloepithelioma, and can make an accurate diagnosis and better treatment.
分析并总结睫状体髓上皮瘤的临床及病理特征。
回顾性分析2007年至2021年在首都医科大学附属北京同仁医院确诊为睫状体髓上皮瘤的11例患者(11只眼)的临床及病理资料。
11例患者的首发症状包括视力下降(6只眼)、眼球萎缩(1只眼)、眼球突出(2只眼)及白瞳症(2只眼)。多数患者伴有角膜混浊、前房闪辉及前房积血。部分病例出现虹膜新生血管及粘连、并发性白内障和继发性青光眼。3例患者甚至发生晶状体半脱位及视网膜脱离。B超显示玻璃体混浊及眼球内中高不均匀回声团块。超声生物显微镜检查显示睫状体球形或半球形肿物,内部回声不均匀,有不规则囊腔。11例患者均经病理证实为恶性睫状体髓上皮瘤。本研究中,6例患者行眼球摘除术(2例术后行全身化疗),另外5例患者行局部肿瘤切除术(1例术后行敷贴放疗)。
睫状体髓上皮瘤是一种罕见的眼内肿瘤,易与视网膜母细胞瘤混淆。分析睫状体髓上皮瘤的临床及病理特征有助于进一步了解该病,从而做出准确诊断并制定更好的治疗方案。